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Abstract
Background: CXCR4, the receptor for the chemokine stromal-derived factor 1 (SDF-1), has
been shown to mediate many of the processes essential for cancer progression such as tumor cell
proliferation, metastasis, and angiogenesis. To understand the role of CXCR4 in the biology of
neuroblastoma, a disease that presents with wide spread metastases in over 50% of patients, we
screened ten patient derived-neuroblastoma cell-lines for basal CXCR4 expression and sought to
identify characteristics that correlate with tumor cell phenotype.
Results: All cell lines expressed CXCR4 mRNA at variable levels, that correlated well with three
distinct classes of CXCR4 surface expression (low, moderate, or high) as defined by flow
cytometry. Analysis of the kinetics of CXCR4 surface expression on moderate and high expressing
cell lines showed a time-dependent down-regulation of the receptor that directly correlated with
cell confluency, and was independent of SDF1. Cell lysates showed the presence of multiple
CXCR4 isoforms with three major species of approximately 87, 67 and 55 kDa associating with
high surface expression, and two distinct species of 45 and 38 kDa correlating with low to null
surface expression. Western blot analysis of CXCR4 immunoprecipitates showed that the 87 and
67 kDa forms were ubiquitinated, while the others were not. Finally, treatment of cells with a
proteasome inhibitor resulted in down regulation of CXCR4 surface expression.
Conclusions: Taken together, these data show that regulation of CXCR4 surface expression in
neuroblastoma cells can occur independently of SDF-1 contribution arguing against an autocrine
mechanism. Additionally these data suggest that post-translational modifications of CXCR4, in part
through direct ubiquitination, can influence trafficking of CXCR4 to the surface of neuroblastoma
cells in a ligand-independent manner.
Background
Neuroblastoma, a pediatric cancer of the sympathetic
nervous system, accounts for roughly 15% of cancer
related deaths in children [1]. A variety of clinical and bio-
logical parameters are currently used for risk-assessment
and outcome prediction, but morbidity and mortality
remain unacceptable, and an urgent need for improved
therapies exists [2]. One emerging candidate for targeted
therapy in cancer and several other diseases is CXCR4 [3-
6]. CXCR4 has been shown to be involved in the major
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aspects of cancer progression, tumor cell proliferation,
metastasis, and angiogenesis, and its involvement in one
or more of these processes has been demonstrated in sev-
eral human malignancies [7-9]. CXCR4, a seven trans-
membrane domain receptor expressed on the surface of a
variety of cells, serves as the receptor for the chemokine
SDF-1, also known as CXCL12. Through interaction with
its ligand, CXCR4 mediates one of the signals that influ-
ence migration of various cells to their endpoint destina-
tions. The most direct evidence for the biological
significance of CXCR4 is seen in murine knockout models
which result in lethality via impaired development of
their hematopoietic, circulatory, and nervous systems
[10,11], indicating an essential role for SDF-1/CXCR4 sig-
naling in normal development. In humans, genetic muta-
tion of CXCR4 is associated with the clinical syndrome
WHIM, in which a truncating mutation results in deregu-
lation of receptor signaling and consequent impairment
of leukocyte function [12,13]. The biological importance
of CXCR4 is further underscored by the observation that
disruption of the SDF-1/CXCR4 axis has consequence on
essential physiological processes such as homing of
hematopoietic stem cells to marrow [14] and migration of
immune cells to inflammatory sites [15], as well as patho-
physiological processes such as HIV uptake by host cells
[16] and cancer progression. Despite its obvious impor-
tance in the progression of several forms of cancer, the
role and nature of CXCR4 function in neuroblastoma
biology is less clear. CXCR4 has been shown to mediate
proliferation of neuroblastoma cells under certain condi-
tions [17]. Additionally, despite reporting little to no
basal surface expression of CXCR4 on the majority of neu-
roblastoma cells they examined one group has reported
SDF-1 mediated chemotaxis and down-regulation of
CXCR4 upon derivatizing one of their cell lines to overex-
press CXCR4 [18]. Others have suggested however that
CXCR4 is not involved in chemotaxis of neuroblastoma
cells [19] and that SDF-1/CXCR4 signaling causes cell
death [20]. In light of these findings the extent to which
basal CXCR4 surface expression occurs in neuroblastoma
cells and the significance in of this expression on the biol-
ogy of these tumors has not been conclusively demon-
strated. Previous work in our lab employing a
transcriptome wide analysis of a large neuroblastoma
sample set was performed to identify genes associated
with the disease and to further refine its classification
[21]. Analysis of results from this data set identified
CXCR4 as one of the genes differentially overexpressed in
metastatic compared to localized primary tumors
obtained at diagnosis, supporting a role for CXCR4 in
neuroblastoma dissemination. In an effort to further
assess CXCR4 expression patterns in neuroblastoma and
the correlation of such patterns with tumor progression,
global expression of CXCR4 in neuroblastoma cells was




Ten human neuroblastoma cell lines (CHP-134, KCN,
KCNR, LAN-5, NB-69, NGP, SH-SY5Y, SK-N-AS, SK-N-FI,
SK-N-SH), all derived from the tumors of patients with
advanced stage neuroblastoma (Stage 3 or 4) were
obtained from the Children's Oncology Group (COG)
and cultured in 75 cm2 cell culture flasks (corning) using
RPMI-1640, supplemented with 10% fetal bovine serum,
2 mM glutamine, and a 1/100 dilution of penicillin/strep-
tomycin/amphotericin B. Cells were grown at 37°C in a
humidified environment of 95% air and 5% CO2 (All cell
culture media reagents were from Invitrogen). SK-N-ASΔ3
was generated by subcloning an expression vector con-
taining the coding sequence for the E3 ubiquitin ligase
cullin-5. Briefly, full length double stranded Cul-5 cDNA
was amplified from total SK-N-AS RNA with primers
designed using Primer3 software http://frodo.wi.mit.edu/
primer3/. Cul-5 cDNA was gel-purified by band excision
and extraction using a QIAquick gel extraction kit (Qia-
gen) followed by sequencing to confirm transcript iden-
tity. Purified Cul-5 cDNA was sub-cloned into a pcDNA4
expression vector using a pcDNA4/HisMax TOPO® TA
Expression Kit (Invitrogen) and competent E-coli trans-
formed following manufacturer's protocol. Positive trans-
formants were identified using ampicillin selective media
followed by sequence analysis to confirm orientation.
After generation, Cul-5 expression vectors were trans-
fected into SK-N-AS cells using Lipofectamine 2000 (Inv-
itrogen) and stable transfectants selected using zeocin.
Unless otherwise indicated all cells were grown to 80-90%
confluency.
Fluorescence-activated Cell Sorting (FACS) Assay
Neuroblastoma cells were cultured as described previ-
ously. For Brefeldin A studies cells were cultured in the
presence of 1 μg/ml Brefeldin A, or a corresponding vol-
ume of DMSO for 7 hrs, prior to harvesting. For Lactacys-
tin studies cells were cultured in the presence of 10 μM
Lactacystin or corresponding volume of PBS overnight.
After culturing, cells were harvested using Versene (0.02%
EDTA in hanks balanced salt solution) and washed twice,
once with culture media, and once with cold PBA (Phos-
phate buffered saline containing 2%BSA and 0.1% NaN3,
pH 7.4). Once washed, cells were adjusted to a concentra-
tion of 1 × 107 cells per ml in PBA and 50 μl of cells were
incubated with 20 μl of the PE-conjugated mouse anti-
human CXCR4 antibody 12G5 (BD Biosciences) at room
temperature for 30 minutes in the dark. Following incuba-
tion with antibody, cells were washed three times in PBA
and analyzed on a BD FACSCaliber Flow Cytometer using
CellQuest Pro Software (BD Biosciences). For negativeMolecular Cancer 2009, 8:126 http://www.molecular-cancer.com/content/8/1/126
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controls PE-conjugated mouse IgG2a was used. One thou-
sand events were counted for each sample to generate a
distribution of fluorescent intensities. The geometric
mean of those intensities was normalized to the geometric
mean obtained from corresponding mouse IgG2a stained
cells. Final data is represented as relative mean fluorescent
intensity from three experiments.
Quantitative PCR
Cells were cultured and harvested as previously described.
Total RNA was isolated from 1 × 107 cells using the Abso-
lutely RNA miniprep kit (Stratagene) following manufac-
turers instructions followed by 1st strand cDNA synthesis
from 5 μg total RNA using the SuperScript Firs-Strand Syn-
thesis System for RT-PCR (Invitrogen) following manu-
facturers instructions. Quantitative PCR was performed
using the CXCR4 TaqMan Gene Expression Assay
Hs00607978 along with simultaneous amplification of
glyceraldehyde phosphate dehydrogenase (GAPDH) as an
endogenous control. Thirty cycles of amplification were
performed and the difference between CXCR4 and
GAPDH cycle threshold values (dCT) were graphed as 1/
dCT. Detection of cul-5 transcripts was performed with
the same method with exception of using TaqMan Gene
Expression Assay Hs00967483_m1. Assays were done in
triplicate
SDF-1 Enzyme-Linked ImmunoSorbent Assay (ELISA)
Cells were cultured as previously described. Prior to har-
vesting, conditioned media was collected and concen-
trated from initial volume of 12 ml to 500 μl by
centrifuging in a Centriplus Model YM-3 centrifugal filter
device at 3000 × g and 4°C in a JA-20 rotor. After concen-
tration, 100 μl aliquots of conditioned media from cell
lines were placed into 96 well microplates coated with
murine anti-human SDF-1α monoclonal antibody and
ELISA based detection of SDF-1 was performed using the
Quantikine Human SDF-1α Immunoassay kit (R&D Sys-
tems). Absolute quantification of SDF-1 levels were deter-
mined by interpolating from a curve of standard SDF-1
concentrations included on the assay plate; uncondi-
tioned culture media was used to correct for background
levels of SDF-1 in the unconditioned culture media.
Assays were performed in triplicate.
Immunofluorescent labeling of CXCR4 and SDF-1 in 
Neuroblastoma Cells
Sterile 15 mm glass coverslips (Fisher) were placed into
150 mm culture dishes containing supplemented RPMI-
1640. SK-N-SH or SH-SY5Y cells were seeded onto cover-
slips and grown at 37°C in a humidified environment of
95% air and 5% CO2. At 80% confluency cells were rinsed
twice with PBS gently in culture dish so as not to become
detached, briefly fixed with a 3.7% formaldehyde solution
in PBS, and washed twice more with PBS. Fixed Cells were
permeabilized using a 10% NP-40 solution in PBS fol-
lowed by washing once in PBS and then transfer to a new
culture dish containing moist paper towels to prevent cov-
erslips from drying. Coverslips were blocked with PBG, a
modified PBS solution containing 0.2% fish gelatin
(sigma) and 0.5% BSA (sigma), for a minimum of 30
minutes. Blocked coverslips were then incubated with 1/
1000 dilutions of mouse anti-CXCR4 monoclonal anti-
body MAB172 and goat anti-SDF-1 antibody MAB310
(R&D Systems) for either 1 hr at room temperature or
overnight at 4°C. After incubation with primary antibod-
ies coverslips were washed three times with PBG followed
by incubation with 1/200 dilutions of FITC-conjugated
donkey anti-mouse and TRITC-conjugated donkey anti-
goat secondary antibodies (Jackson ImmunoResearch) for
1 hr at room temperature or 4°C overnight. Following
incubation with secondary antibodies coverslips were
washed three times with PBG with the inclusion of 0.5 μg/
ml of 4', 6-diamino-2-phenylindole (Sigma) in the third
wash. Coverslips were then washed twice with PBS,
mounted onto 3'' × 1'' × 1 mm glass microscope slides
(Fisher) with Gel/Mount embedding medium containing
anti-fading agents (Biomedia), and sealed with liquid
enamel (Revlon). Fluorescently labeled cells were visual-
ized using immune complexes were visualized using an
inverted fluorescent microscope. Figure shows a superim-
posed composite of CXCR4 and SDF-1 imaging.
Western Blot Detection of CXCR4
Cells were cultured as previously described. After harvest-
ing 1 × 107 cells were washed twice in PBS and solubilized
in 1 ml of lysis buffer consisting of 50 mM Tris base, 150
mM NaCl, 1% Triton X-100 pH 7.5. Cell lysates were cen-
trifuged at 14, 000 rpm and 4°C for 30 minutes in a table-
top refrigerated centrifuge (Eppendorf) and supernatants
were analyzed for total protein content by performing the
DC Protein Assay (Bio-Rad) and measuring absorbance at
750 nm on a Benchmark Plus Microplate Spectrophotom-
eter (Bio-Rad). Total protein concentrations in cell line
samples were determined by interpolation from a linear
curve of BSA values. Proteins were resolved by electro-
phoresis using the Xcell SureLock Mini-Cell system (Invit-
rogen) following manufacturer's instructions. Briefly, 1 μg
of total protein for each cell line was loaded onto a
NuPAGE 4-12% Bis-Tris Gel followed by electrophoresis
at 200 constant volts for 40 minutes. High-Range Rain-
bow Molecular Weight Markers (Amersham Biosciences)
were simultaneously run with samples in separate lanes to
monitor resolution. Following electrophoresis resolved
proteins were transferred to Hybond ECL Nitrocellulose
membranes (Amersham Biosciences) at 30 constant volts
for 1 hr at room temperature using an Xcell II Blot Module
(Invitrogen) following manufacturer's instructions. Trans-
fer efficiency was assessed by briefly staining membranes
with a 0.1% Ponceau S solution in 5% Acetic acid (Sigma)Molecular Cancer 2009, 8:126 http://www.molecular-cancer.com/content/8/1/126
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followed by rinsing in deionized distilled H2O. After
removal of Ponceau S western blot detection was per-
formed using an ECL Western Blot Detection Kit (Amer-
sham Biosciences) following manufacturer's instructions.
Briefly, membranes were blocked in 5% blocking solu-
tion, rinsed in TBS pH 7.6 containing 0.1% Tween 20
(TBS-T), and incubated with a 1/1000 dilution of the rab-
bit anti-human CXCR4 antibody ab2090 (abcam) at
either room temperature for 1 hr or overnight at 4°C. Fol-
lowing adsorption of primary antibody, membranes were
rinsed in TBS-T and then incubated with a 1/2000 dilu-
tion of horseradish peroxidase (HRP) conjugated anti-
rabbit antibody for 1 hr at room temperature. Following
incubation with secondary antibody membranes were
washed extensively and a chemiluminescent substrate for
1 min at room temperature. Labeled molecules were visu-
alized by 30 second dark room exposure onto Hyperfilm
ECL chemiluminescence film in a BioMax Cassette
(Kodak) and development on an M35 X-OMAT processor
(Kodak). Determination of molecular mass was per-
formed by linear interpolation from a curve of chemilu-
minescent standards (Amersham Biosciences) run along
side samples during electrophoresis. For Cul-5 western
blot detection procedure was the same as for CXCR4
detection with the exception of using a 1/200 dilution of
ab82292, a rabbit polyclonal antibody specific for the car-
boxy terminus of CUL-5 (abcam), as the primary anti-
body. For Ubiquitin western blot detection lysates were
adsorbed with 10 μg/ml of the rabbit anti-human anti-
body OPA1-01100 (Affinity BioReagents) overnight at
4°C. Immune complexes were bound to pre-washed Pro-
tein G Agarose beads (Invitrogen) by incubating for 1 hr
at room temperature followed by precipitation by centrif-
ugation at 10, 0000 × g for 10 minutes at room tempera-
ture. CXCR4 immunoprecipitates were washed
extensively with lysis buffer and TBS-T prior processing in
sample buffer and loading onto gels for electrophoresis.
Western blot detection of ubiquitin in CXCR4 immuno-
precipitates was performed similarly as for CXCR4 west-
ern blots except membranes were incubated with the
mouse anti-human ubiquitin primary antibody MAB701
(R&D Systems) and an HRP-conjugated anti-mouse sec-
ondary antibody (Amersham Biosciences) at 1/1000 and
1/2000 respectively.
Results
CXCR4 is Differentially Expressed in Neuroblastoma Cells
Ten human neuroblastoma-derived cell lines from
patients with high-risk disease were screened for surface
expression of CXCR4 by flow cytometry. An overlay of the
representative frequency distribution of fluorescence
intensities for each cell line resulted in the peak intensities
clustering into one of three distinct regions (Fig. 1A). Fig
1B shows a quantitative representation of the range of
normalized geometric mean intensities from three experi-
ments for each of the cell lines. The M.F.I. for each cell line
was assigned to one of three classes of expression based on
the following cutoffs; <5 for low, 5-20 for medium, and
greater than 20 for high. Fig. 1C shows a comparison of
the mean value of intensities in the three defined classes
to demonstrate the significant difference between them as
determined by one-way ANOVA analysis (P < 0.0001).
Table 1 shows the assignment of each cell line to one of
the three defined surface expression classes. To determine
if the observed variability in CXCR4 surface expression
was related to transcriptional regulation, quantitative RT-
PCR was performed to compare CXCR4 mRNA copy
number in the panel of neuroblastoma cell lines. Fig. 2A
shows a similar pattern of heterogeneity with regard to
CXCR4 transcriptional expression. With the exception of
three cell lines, CHP-134, NB-69, and SK-N-SH, the same
order of expression seen at the surface level was main-
tained at the transcriptional level. The same class assign-
ment given in surface expression analysis was used for
assessing transcriptional expression and as can be seen in
fig. 2B this similarly resulted in the generation of three sta-
tistically distinct classes of mean transcriptional expres-
sion (P < 0.005, one-way ANOVA). To determine how
closely transcriptional expression reflects the expression
of CXCR4 at the cell surface, nonlinear regression analysis
was performed using the respective means for each cell
line. Fig. 2C shows there was a strong correlation (Pearson
correlation, R2 = 0.9235, P < 0.05) between the two types
of expression but that transcription alone was not a com-
plete indication of CXCR4 surface levels.
Autocrine Mediated Down-Regulation of CXCR4 does not 
occur in Neuroblastoma Cells
Previous reports have shown that CXCR4 is down-regu-
lated at the neuroblastoma cell surface in response to
exogenously added SDF-1 leading to the hypothesis that
CXCR4 surface expression is regulated by a negative auto-
crine feed back loop mediated by an accumulation of
SDF-1 secreted from neuroblastoma cells [18]. In an effort
to assess the possible effects of endogenously derived
SDF-1 accumulated during cell culture on CXCR4 surface
expression, cells at different degrees of confluency were
measured for CXCR4 at the cell surface using flow cytom-
etry. As shown in fig. 3, increasing confluency resulted in
a progressive decrease in CXCR4 at the surface of cells in
the higher surface expressing classes, demonstrating a sig-
nificant correlation between cell density and surface
expression of the receptor (Pearson correlation analysis,
R2 = 0.9488; P < 0.05); this observation was consistent for
all of the moderate to high CXCR4 surface expressing cell
lines tested. SH-SY5Y, a sub-clone of SK-N-SH and a low
surface expressing cell line showed no difference in
CXCR4 surface expression at any confluency; this observa-
tion was consistent for all cells in the low CXCR4 surface
expressing class. Maximal CXCR4 surface expression wasMolecular Cancer 2009, 8:126 http://www.molecular-cancer.com/content/8/1/126
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observed for cell cultures less than 50% confluent (data
not shown), and upon 100% confluency CXCR4 surface
expression was reduced to half maximal levels.
Autocrine downregulation of CXCR4 by endogenously
derived SDF-1 in the extracellular medium has previously
been suggested to explain the low levels of CXCR4 seen on
some neuroblastoma cell lines [18]. In an effort to test this
theory and more accurately assess basal levels of CXCR4
surface expression an attempt was made to block release
of any endogenous SDF-1 and prevent receptor down-reg-
ulation by treating cells with Brefeldin A, an inhibitor of
CXCR4 is Differentially Expressed on the Surface of Neuroblastoma Cells Figure 1
CXCR4 is Differentially Expressed on the Surface of Neuroblastoma Cells. Neuroblastoma cells were cultured to 
80% confluency, harvested with versene followed by washing in culture media, then a modified phosphate buffered saline 
(PBA). 5 × 105 intact and non-permeabilized cells were incubated with a PE-conjugated Anti-CXCR4 monoclonal antibody 
(12G5) for 30 minutes, washed and flow cytometry was performed to measure cell surface associated fluorescence. A) Fre-
quency histogram showing distribution of fluorescent intensities associated with cell surface of labeled cells. Fluorescent inten-
sity is shown on the x-ordinate and the number of cell events on the y-ordinate. A total of 1000 events were recorded for each 
measurement. Three distinct ranges of distribution are evident (brackets). Data shown is from one experiment and is repre-
sentative of results obtained from three experiments. B) The geometric mean fluorescent intensity for each cell line was 
determined after staining with anti-CXCR4 antibody, this value was then normalized to the corresponding geometric mean flu-
orescent intensity obtained from surface staining each cell line with the PE-conjugated isotype matched control antibody 
(Mouse IgG2a). Final quantitative values are represented as a relative mean fluorescent intensity (M.F.I.) +/- SD obtained, from 
three experiments. Means were stratified into three classes of surface expression and the following cutoffs were used to define 
each class: Low= M.F.I. <5; Medium = M.F.I. 5-20; High = M.F.I. >20 (see table 1). C) The mean plus SD was determined for 
each surface expressing class using the intensities of all the cell lines in that class. The mean value of each class falls within the 
parameters used to define that class. All means were significantly different from one another. (*P < 0.0001, One-way ANOVA).Molecular Cancer 2009, 8:126 http://www.molecular-cancer.com/content/8/1/126
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vesicular protein secretion. As shown in fig. 4, Brefeldin A
treatment did not result in a recovery of CXCR4 on the
surface of the low expressing cell line SH-SY5Y, this obser-
vation was true for the other low expressing cell lines as
well (data not shown). In addition, NGP and SK-N-SH,
moderate and high surface expressing cell lines respec-
tively, both showed significant decreases in surface levels
as a consequence of Brefeldin A treatment (paired t test, P
< 0.005); this observation was also made for the other
moderate and high expressing cell lines from our panel
(data not shown). In light of the absence of any upregula-
tion of CXCR4 on the surface of Brefeldin A treated cells
we decided to determine the presence and abundance of
any endogenously derived SDF-1 in the extracellular envi-
ronment of neuroblastoma cell lines used by us. Quanti-
tative ELISA was performed on conditioned medium
collected from cells at 100% confluency. As shown in fig.
5, SDF-1 levels observed in representatives from the high
(SK-N-SH or LAN-5), or the low (SH-SY5Y) surface
expressing classes were either at, or below background lev-
els of the chemokine measured in culture media (8 pg/
ml), and found not to be significant (P > 0.05, One-way
ANOVA). The concentration of extracellular SDF-1 for the
moderate surface expressing cell line NGP, calculated at
184 pg/ml, was significantly higher than background lev-
els of SDF-1 (P > 0.005, One-way ANOVA); however this
level was determined to be below levels used to activate
CXCR4 and deemed physiologically irrelevant [18]. With
the exception of NGP, SDF-1 levels were observed to be
below background levels for all the other cell lines exam-
ined regardless of expression class (data not shown). In an
attempt to clarify the status of endogenously expressed
SDF-1 in neuroblastoma cells localization of the chemok-
ine was assessed using indirect fluorescent immunostain-
ing. SDF-1 was present in both the high surface expressing
cell line (SK-N-SH) and its low surface expressing sub-
clone (SH-SY5Y) (Figs. 6A and 6B), and appeared to local-
ize predominately at the inner periphery of the plasma
membrane. Staining in SK-N-SH cells appearing more
focal and polarized with respect to CXCR4, while SH-
SY5Y cells showed a more diffuse staining pattern; there
was little to no co-localization of SDF-1 and CXCR4 in
either cell line. The staining pattern for SK-N-SH was
observed for all medium and high CXCR4 surface express-
ing cell lines in our panel while the pattern for SH-SY5Y
was observed for all the low surface expressing lines (Data
not shown). Transcriptional expression of SDF-1 was
determined in all cell lines examined to confirm their abil-
ity to endogenously synthesis the chemokine (Data not
shown).
Regulation of CXCR4 Surface Expression is associated 
with Structural Heterogeneity
CXCR4 has been shown to display significant structural
heterogeneity, [22] yet to date no extensive analysis of
CXCR4 secondary structure in neuroblastoma has been
performed. Western blot analysis of CXCR4 was per-
formed on all the cells in our panel in an attempt to iden-
tify any structural heterogeneity of CXCR4 that might
further refine our stratification of CXCR4 surface expres-
sion. Fig. 7A shows a significant degree of structural heter-
ogeneity for CXCR4 with several isoforms being
differentially represented across the three classes of sur-
face expressing lines. Of the various isoforms present five
Table 1: Classification of Neuroblastoma Cell Lines by CXCR4 Surface Expression










LAN-5 63.33 HighMolecular Cancer 2009, 8:126 http://www.molecular-cancer.com/content/8/1/126
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appeared to differentially segregate between the high and
low surface expressing classes, and served to help further
characterize and distinguish between these two classes.
Two major forms of approximately 38 and 45 kilodaltons,
corresponded well to reported masses for native and glyc-
osylated forms of CXCR4 respectively [22,23], and were
present exclusively in the low CXCR4 surface expressing
cell lines. Three major forms of approximately 55, 67, and
87 kilodaltons and equal stoichiometry appeared to pri-
marily associate with the high surface expressing class. It
should be noted that to varying degrees these isoforms
were also present in the moderate class of surface express-
ing cell lines, however without the same stoichiometry.
The presence of a large diffuse component spanning the
67-87 kDa regions in four of the five low surface express-
ing cell lines was observed. This material did not appear
as a discrete band and was seen on immunoblots with
anti-CXCR4 (Fig. 7A), as well as with isotype control
immunoblots and on Ponceau S stained membranes prior
to immunoblotting (data not shown). CXCR4 has been
shown to be ubiquitinated, in a basal and agonist-induced
manner, contributing to the degree of heterogeneity fre-
quently observed upon secondary structural analyses
[23,24]. To determine if any of the isoforms we observed
were ubiquitinated, CXCR4 was immunoprecipitated
from cell lysates followed by western blotting with anti-
Transcriptional Expression of CXCR4 in Neuroblastoma Cells Figure 2
Transcriptional Expression of CXCR4 in Neuroblastoma Cells. Total RNA was isolated from each cell line and used 
to generate cDNA templates. Quantitative PCR was performed using a total of 250 ng of template cDNA for each cell line and 
30 cycles of amplification. A) CXCR4 mRNA levels in panel of ten neuroblastoma cell lines. dCt values for CXCR4 were nor-
malized to the endogenous control glyceraldehyde phosphate dehydrogenase. dCt values represent the average of three repli-
cates. B) The mean dCt value for each surface expression class was generated from all dCt values of cell lines in a given class. 
Result shows the mean dCt +/- SD of each class to be significantly different from one another (P < 0.005, One-way ANOVA). 
C) The log10 of mean fluorescent intensity was plotted against the mean dCt for each cell line. Each data point represents the 
mean value obtained from three FACS assays plotted against the mean value obtained from three quantitative PCR assays. Fig-
ure shows a strong and significant correlation between the two forms of expression (Pearson correlation, R2 = 0.9235, P < 
0.05).Molecular Cancer 2009, 8:126 http://www.molecular-cancer.com/content/8/1/126
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ubiquitin monoclonal antibody. There were two bands of
approximately 68 and 72 kilodaltons present to varying
degrees in all of the cell lines (Fig. 7B); The 68 kilodalton
ubiquitinated molecule appears to correspond to the 67
kilodalton isoform described earlier as one of the three
associated with high surface expressing cell lines (Fig. 7A).
The 72 kilodalton ubiquitinated molecule is also believed
to be a CXCR4 isoform observed in cell lines from both
the high and moderate surface expressing lines, albeit not
to the same extent. Attachment of ubiquitin serves as a pri-
mary signal to identify proteins targeted for turnover by
the proteasome. SK-N-AS is known to be deleted at Chro-
mosome 11q23 [25], a region which contains the gene for
Cul 5, a component of the E3 ubiquitin ligase complex
that mediates proteasomal degradation [26]. Comparison
between SK-N-AS and SK-N-AS 3, a derivative cell line
transfected with a Cul 5 expression vector, shows a shift
occurred from the low surface expressing to high surface
expressing CXCR4 structural profile respectively (Fig. 7A);
this conversion appears to be associated with changes in
Cul 5 expression levels (Fig. 8A). In an effort to further
evaluate proteasomal-mediated targeting of CXCR4 as a
possible mechanism for regulating its surface expression,
neuroblastoma cells were treated with the irreversible pro-
teasome inhibiting agent Lactacystin. Fig. 8B shows treat-
ment of the high CXCR4 surface expressing cell line SK-N-
SH with this compound resulted in a significant decrease
in surface levels of the receptor relative to untreated cells
(P < 0.005, paired t-test). The low surface expressing SH-
SY5Y showed no significant changes in CXCR4 levels.
These observations were similar for the other high and
low surface expressing cells in our panel respectively
(Data not shown).
Discussion
The purpose of this study was to evaluate the expression
of CXCR4 in neuroblastoma cells and determine to what
extent, if any, expression of this receptor may contribute
to the heterogeneity associated with the disease. Using a
panel of ten cell lines derived from patients with high-risk
neuroblastoma, we compared CXCR4 expression at both
the cell surface and transcriptional levels (Figs. 1 &2).
Effect of Cell Density on CXCR4 Surface Expression Figure 3
Effect of Cell Density on CXCR4 Surface Expression. Individual flasks of culture media were each synchronously seeded 
with 5 × 106 SK-N-SH cells and grown at 37°C to varying confluency. At each confluency, cells were harvested and processed 
for cell surface staining of CXCR4. The maximum CXCR4 signal was observed at 50% confluency and set as 100% mean fluo-
rescent intensity. All intensities are represented as % relative values normalized to the maximum intensity. Result represents 
the mean from three experiments and shows the correlation between cell density and surface expression (Pearson correlation, 
R2 = 0.9488, P < 0.05).Molecular Cancer 2009, 8:126 http://www.molecular-cancer.com/content/8/1/126
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Transcriptionally, CXCR4 was variably expressed in all of
the cell lines examined (Fig. 2A); this observation was
made for surface expression as well (Fig. 1B) and subse-
quently used to stratify cell lines into three categories of
expression (Table 1). While overall a direct correlation
between transcriptional and surface expression of CXCR4
was observed (Fig. 2C), the margin of difference in tran-
script levels were not as large as, and hence reflective of,
the differences witnessed for surface expression of the pro-
tein. It is reasonable to expect that assessment of gene
expression using two separate markers (cDNA and cell
membrane protein), and hence techniques, might pro-
duce results varying in scale based solely on differences in
the dynamic range and sensitivity of the assays used. The
extent of difference observed when transcriptional and
surface expression levels from the same cell line are com-
pared however suggests that some post-transcriptional/
translational event is involved in regulating the final
expression of CXCR4 on the surface of neuroblastoma
cells.
It had previously been suggested that surface expression of
CXCR4 on neuroblastoma cells was subject to SDF-1
mediated down-regulation via a negative autocrine loop
mechanism [18]. An autocrine mechanism such as the
one suggested for CXCR4 regulation should be dependent
on the production and subsequent release of SDF-1 from
neuroblastoma cells prior to ligand-receptor binding and
internalization, and would thus be preceded by the accu-
mulation of ligand in the extracellular environment in a
time and cell density dependent manner. While we did
observe decreases in CXCR4 surface levels over increasing
time and cell confluency (Fig. 3), results from ELISA
experiments performed on media from confluent cultures
of neuroblastoma cells revealed negligible levels of SDF-1
(Fig. 5), this was despite the detection of SDF-1 transcripts
(data not shown) and protein (Fig. 6) inside the cells. It is
worth noting there was one cell line, NGP, in which some
SDF-1 was detected via ELISA (Fig. 5), however the maxi-
mum concentration detected (184 pg/ml) was more than
an order of magnitude below the minimum concentration
of exogenous SDF-1 (10 ng/ml) used to mediate CXCR4
down-regulation in neuroblastoma cells [18]. This obser-
vation, coupled with the failure of the secretory inhibitor
Brefeldin A to rescue CXCR4 from down-regulation,
strongly suggest a lack of autocrine regulation of CXCR4
in the cell lines we examined. Interestingly, Brefeldin A
treatment resulted in a decrease in CXCR4 cell surface
Effect of the Secretion Inhibitor Brefeldin A on CXCR4 Surface Expression Figure 4
Effect of the Secretion Inhibitor Brefeldin A on CXCR4 Surface Expression. Various cell lines from all three surface 
expression classes were cultured with the addition of 1 μg/ml Brefeldin A. Cells were left at 37°C for 12 hrs, harvested, 
washed, and processed for FACS analysis. Result represents the M.F.I. +/- SD from three experiments (*P < 0.05, Paired t-test).Molecular Cancer 2009, 8:126 http://www.molecular-cancer.com/content/8/1/126
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expression (Fig. 4), possibly due to disruption of receptor
recycling from intracellular vesicles to the cell surface. The
presence of detectable SDF-1 at both the mRNA (data not
shown) and protein levels (Fig. 6) suggest that this chem-
okine was produced by the neuroblastoma cell lines we
examined. Failure to find SDF-1 in the extracellular media
however may be an indication that the cells were either
defective in their ability to secrete it, or the appropriate
stimulus was not present to elicit its secretion. Although
we considered the possibility that neuroblastoma cells in
this study were not presented with the appropriate stimuli
for secretion of SDF-1, the fact that they were cultured in
the presence of 5% fetal bovine serum, a concentration
greater than that shown to stimulate SDF-1 secretion from
glioblastoma cells [27] strongly suggested otherwise.
We hypothesized that the differential expression of
CXCR4 in neuroblastoma cells might be due to post-trans-
lational modifications that influenced its trafficking to the
cell surface. Structural heterogeneity of CXCR4 due to
post-translational modification has been widely demon-
strated in a variety of cell types. These modifications have
in large part been attributed to glycosylation or ubiquiti-
nation of CXCR4 and in some cell types has been associ-
ated with different functional responses [22,23]. Given
that to our knowledge no such observations have been
reported in neuroblastoma cells we examined whether
this heterogeneity was present in our cell lines as well, and
if so to what extent it might be associated with differential
surface expression of the receptor. In our examination of
CXCR4 we found the degree of structural heterogeneity to
be high (Fig. 7A), observing what appeared to be many of
the same isoforms reported by others [22,23]. Of the iso-
forms we observed we noted some that were more prom-
inently associated with cells in certain surface expression
classes such as, the moderate to high class more strongly
expressing isoforms of 55, 67, and 87 kDa, and the 38 and
45 kDa isoforms more prominently associated with the
low surface expressing class. It is compelling to speculate
whether these two classes of isoforms respectively regulate
opposing CXCR4 mediated responses such as, the prolif-
erative and cytotoxic signaling in response to SDF-1 stim-
ulation observed in two different neuroblastoma cell lines
[17,20]. Another important consideration is the possibil-
ity that the association of these structural isoforms with
differential expression of CXCR4 at the cell surface is
based solely on alterations in epitopes which could result
in a loss of recognition by the antibody used for surface
Quantitative Analysis of SDF-1 Secretion by Neuroblastoma  Cells Figure 5
Quantitative Analysis of SDF-1 Secretion by Neurob-
lastoma Cells. Conditioned media from several neuroblast-
oma cell lines was collected at maximum confluency. 
Conditioned media was concentrated from 12 ml to 0.5 ml 
by filter centrifugation using membranes with 3000 molecular 
weight cut-offs. Quantitative Analysis of SDF-1 was per-
formed using an enzyme linked immunoadsorbent assay 
(ELISA). Result represents the mean of three experiments 
for representatives from each surface expressing class com-
pared to media background levels (*P < 0.005 and **P > 0.05, 
unpaired t-test).Concentrations are expressed in pg/ml.
Immunofluorescent Staining of CXCR4 and SDF-1 in Neu- roblastoma Cells Figure 6
Immunofluorescent Staining of CXCR4 and SDF-1 in 
Neuroblastoma Cells. Cells were seeded onto coverslips 
and grown to 80% confluency. At desired confluency cells 
were fixed with 3.7% formaldehyde, permeabilized with 10% 
NP-40 and blocked with PBG. CXCR4 and SDF-1 immune 
complexes were generated by incubating cells with 1/1000 
dilutions of the mouse anti-CXCR4 monoclonal antibody 
MAB172 and the goat anti-SDF-1 antibody MAB310 respec-
tively. 1/200 dilutions of FITC-conjugated donkey anti-mouse 
and TRITC-conjugated donkey anti-goat antibodies were 
used to localize CXCR4-MAB172 complexes respectively. 
Immune complexes were visualized using an inverted fluores-
cent microscope. Figures show superimposed composites of 
CXCR4 and SDF-1 imaging from the same fields of vision. 
(A) SK-N-SH cells. (B) SH-SY5Y cells. Result is a represent-
ative image taken from ten separate fields of vision.Molecular Cancer 2009, 8:126 http://www.molecular-cancer.com/content/8/1/126
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staining, however we have seen the same surface expres-
sion patterns using a different CXCR4 antibody, MAB-172
(data not shown). Additionally, isoforms similar to the
ones observed by us to associate with low surface expres-
sion were detected in lymphoblastic leukemic cells via
western blotting using the same anti-CXCR4 antibody
used in this study to measure surface expression,12G5
[22]. In light of these observations it is unlikely that the
differential surface expression witnessed here is reflective
of differences in epitope recognition and not protein lev-
els. We also observed differential overexpression of a non-
CXCR4 protein component that appeared only in low
Analysis of CXCR4 Structural Heterogeneity in Neuroblastoma Cells Figure 7
Analysis of CXCR4 Structural Heterogeneity in Neuroblastoma Cells. A) Western Blot Detection of CXCR4 in 
Neuroblastoma Cell Lysates. Cell lysates were generated by solubilizing neuroblastoma cells in 1% triton X-100. Detergent sol-
uble proteins were resolved on 4-20% Bis-Tris SDS gels and transferred to nitrocellulose membranes. CXCR4 was detected by 
probing with a rabbit anti-human CXCR4 polyclonal primary antibody (ab2090), followed by a horse radish peroxidase conju-
gated donkey anti-rabbit secondary antibody, and then chemiluminescent substrate. CXCR4 was visualized using enhanced 
chemiluminescent (ECL). The samples represented are as follows: Lane 1- CHP-134, Lane 2-KCN, Lane 3-KCNR, Lane 4-NB-
69, Lane 5-NGP, Lane 6-SK-N-FI, Lane 7-SK-N-AS, Lane 8-SK-N-ASΔ3*, Lane 9-LAN-5, Lane 10-SK-N-SH, Lane 11-SH-SY5Y. 
Cell lines are color coded by surface expression class: Red = Low, Blue = Medium, Green = High, Black = Not Conclusively 
Determined (N.D.). *SK-N-ASΔ3 is a derivative cell line of SK-N-AS that has been transfected with an expression vector con-
taining the coding sequence for an E3 ubiquitin ligase component Cullin-5 (CUL-5). All samples were loaded equally as deter-
mined by comparing actin levels in each lane (Data not shown). B) Western Blot Detection of Ubiquitin in CXCR4 
Immunoprecipitates. Cell lysates were adsorbed with rabbit anti-human CXCR4 antibodies followed by precipitation with pro-
tein G Agarose. Precipitated CXCR4 Immune complexes were resolved on 4-15% Bis-Tris SDS gels and transferred to nitro-
cellulose membranes. Membranes were probed with a mouse anti-human Ubiquitin monoclonal antibody followed by an HRP-
conjugated donkey anti-mouse secondary antibody, and then addition of chemiluminescent substrate. Ubiquitin was visualized 
by measuring ECL. Sample order is the same as in panel A.Molecular Cancer 2009, 8:126 http://www.molecular-cancer.com/content/8/1/126
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expressing cell lines (Fig. 7A); this material diffusely local-
ized between 67 and 87 kDa on blots with immune and
non-immune antibodies but was not observed however
when CXCR4 blots were performed following CXCR
immunoprecipitation (data not shown). In our attempts
to identify the nature of the various isoforms observed by
us we examined our cells for the presence of ubiquitinated
CXCR4 via western blotting (Fig. 7B). Two CXCR4 associ-
ated proteins were found to cross-react with anti-ubiqui-
tin antibodies, a 68 kDa species which we believe
corresponds to the 67 kDa isoform seen in CXCR4 immu-
noblots from high surface expressing cell lines, and a 72
kDa protein. Based on our observation, and an earlier
report suggesting a 68 kDa isoform to represent a non-gly-
cosylated CXCR4 dimer [22], it is likely our 67 kDa iso-
form represents a ubiquitinated CXCR4 dimer. With
regard to the 72 kDa isoform, while we have seen bands
of this size on our CXCR4 immunoblots, albeit not as
consistently and to a much lesser degree than the other
isoforms, it is possible that this particular isoform does
not cross react strongly with the monoclonal antibody
used in the CXCR4 immunoblot assays; alternatively, it
may represent a co-immunoprecipitating molecule that is
ubiquitinated. Despite demonstrating the ubiquitination
of at least one CXCR4 isoform we were not able to conclu-
sively associate this particular modification with any one
class of CXCR4 surface expression. In light of observing
posttranslational modification of CXCR4 with ubiquitin
in neuroblastoma cells we decided to examine what effect
if any, treatment with the irreversible proteasome inhibi-
tor lactacystin would have on surface expression of
CXCR4. A previous report had shown an increase in
CXCR4 surface expression after lactacystin treatment in
monocytes, which was believed to be due to a rescue of
the receptor from proteasomal degradation [23]. Our
examination revealed a decrease in surface expression of
CXCR4 on medium to high expressing neuroblastoma
cells following treatment with lactacystin (Fig. 8B); we
speculate that this may be due to decreased proteasomal
degradation of a negative regulator of CXCR4 surface
expression resulting in enhanced downregulation of sur-
face expression. Despite our inability to conclusively dem-
onstrate a direct correlation between ubiquitination
patterns and surface expression class we did observe that
stable transfection of our SK-N-AS cell line with a CUL-5
expressing construct (Fig. 8A) resulted in a derivative cell
Evidence for Proteasomal Regulation of CXCR4 Structure-Function Figure 8
Evidence for Proteasomal Regulation of CXCR4 Structure-Function. A) Comparison of Cul-5 Expression in SK-N-
AS vs. SK-N-ASΔ3 Cells. Top-Quantitative PCR was performed for 30 cycles of amplification using CUL-5 primers and a total of 
250 ng of template cDNA from either SK-N-AS or SK-N-ASΔ3. Result represents the mean +/- SD from three experiments 
(*P < 0.005, paired t-test). dCt values for CUL-5 transcripts were normalized to the endogenous control glyceraldehyde phos-
phate dehydrogenase. Bottom-Western blot was performed on total cell lysates from SK-N-AS and SK-N-ASΔ3 cells using 
anti-CUL-5. B) Effect of Proteasomal Inhibitor Lactacystin on CXCR4 Surface Expression. Cells were cultured in the presence 
of 10 μM of lactacystin. After 12 hrs of treatment cells were harvested and processed for FACS analysis. The high CXCR4 sur-
face expressing cell line SK-N-SH and its low surface expressing subclone were both analyzed. PBS was used as a negative con-
trol.Molecular Cancer 2009, 8:126 http://www.molecular-cancer.com/content/8/1/126
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line (SK-N-ASΔ3) that was characterized by conversion of
its CXCR4 structural profile from one with prominent
expression of the 38 and 45 kDa isoforms as observed in
the low surface expressing cell lines, to one with strong
expression of the 55, 67, 87 kDa isomers observed in high
surface expressing cell lines (Fig. 7A). The CUL-5 tran-
script encodes a component of the E3 ubiquitin ligase
which is a part of the proteasomal complex involved in
attachment of ubiquitin molecules to targeted proteins
and has been associated with breast tumorigenesis [26];
interestingly, this gene is found in a region of chromo-
some 11q we have shown to be commonly deleted in neu-
roblastoma and associated with poor outcome [28].
Initial attempts to associate this conversion of CXCR4 iso-
forms with a change in surface expression level were not
successful; however we did notice that this change
resulted in SK-N-AS, one of the more aggressively growing
and tumorigenic cell lines, becoming much less tumori-
genic in nude mice (data not shown). To our knowledge
the only E3 ligase associated with CXCR4 is atrophin
interacting protein 4 (AIP4) [29]; these observations have
in large part been made in cells of hematopoeitic lineage.
Given that in the proteasomal complex there is a far
greater diversity of E3 components than E1 components,
and to a lesser extent E2 components, E3 ligases confer a
majority of the specificity for substrate recognition to the
proteasomal complex [30]. Based on this, the possibility
that in neuroblastoma cells an E3 ligase other than AIP4,
possibly Cul-5, mediates modification of CXCR4 is
intriguing. The combined observations that down-regula-
tion of CXCR4 occurred in the absence SDF-1 stimulation,
and in response to lactacystin treatment, may potentially
underscore a novel mechanism of GPCR regulation. Such
a mechanism might involve proteasomal mediated mod-
ification of CXCR4, possibly with ubiquitin, which targets
CXCR4 to the surface of neuroblastoma cells as opposed
to lysosomal degradation. If such a mechanism were to
exist then the ligand independent downregulation we
observed could represent the kinetic turnover of post-
translationally modified CXCR4 whereby a molecule such
as ubiquitin is cleaved off of CXCR4 resulting in its inter-
nalization and degradation. An example of this type of
mechanism is exhibited in the constitutive activation of
another seven transmembrane domain receptor, Protease-
activated receptor-1 (PAR1) [31].
Conclusions
Taken together, our data show that CXCR4 is widely
expressed at variable levels on the surface of patient-
derived neuroblastoma cell lines. We believe this variabil-
ity is in large part due to structural heterogeneity of the
receptor as a result of post-translational modifications
and that these modifications are in some small part due to
ubiquitination, but more probably to a greater extent due
to oligomerization. Additionally, it appears that direct or
indirect regulation by proteasomal components not yet
identified are involved in the regulation of CXCR4 on the
surface of neuroblastoma cells, and that this regulation
can occur independent of stimulation by agonist as evi-
denced by the absence of any apparent endogenously
derived SDF-1. Furthermore, the apparent lack of endog-
enous SDF-1 involvement in our studies demonstrate that
regulation of CXCR4 surface expression can occur in a
non-autocrine, SDF-1 independent manner, which sug-
gests that this chemokine is not the sole obligatory signal
for all CXCR4 mediated activity, a likelihood which was
first underscored in a study using neuroblastoma cells that
were metastatically active and positive for CXCR4 surface
expression yet desensitized to SDF-1 [19]. Initial efforts by
our laboratory to demonstrate a functional difference
between CXCR4 mediated responses in our low versus
high surface expressing cell lines were unsuccessful (data
not shown) however the contribution of other, not yet
identified factors which may be present in the much more
ï¿½factor-richï¿½ environment of the biological stroma
can not be ruled out. Recent work has demonstrated that
expression of CXCR4 in neuroblastoma cells can be differ-
entially regulated by exposure to stromal components,
and that the nature of this regulation can vary dependent
on both the cell line being examined and the tissue origin
of the stroma. In their study the authors identified liver
stromal-derived IFN-γ and IL-5γ as two components hav-
ing positive and negative regulatory effects respectively on
CXCR4 expression in one of their cell lines and were able
to directly correlate expression with cell migration.
Although not reported it would be interesting to know if
the authors observed any of the structural heterogeneity
we identified to be associated with the differential expres-
sion and chemokine/receptor modulations witnessed in
their study. It should be noted that the authors used
mouse-derived stromal cells to influence CXCR4 expres-
sion on human neuroblastoma cells, however in the con-
text of our findings the possible contributory effects from
other stromal-derived cytokines such as IFN-γ and IL-5γ
on the expression and function of CXCR4 in our system
warrant investigation. Further work will focus on identify-
ing the nature of the CXCR4 modifications that exist in
neuroblastoma cells and the extent, if any, to which these
isoforms regulate the various CXCR4 mediated responses.
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